The DNAs of human papillomavirus (HPV) types 4, 16 and 18 have been detected in biopsies of normal and malignant human oral mucosa by Southern blot hybridization and the polymerase chain reaction (PCR) . By the former technique, HPV-4, HPV-16 and HPV-18 DNAs were detected in three separate carcinomas but were found in adjacent dysplastic and normal tissue by the PCR only. The PCR technique also allowed detection of HPV-16 and HPV-18 DNA in additional carcinomas and normal samples. The oral HPV-4 DNA was molecularly cloned and extensive restriction analysis and nucleotide sequencing showed identity with the prototype HPV-4 DNA. The HPV-18 DNA detected by Southern blot hybridization showed an altered restriction pattern in the E1 region of the viral genome; however direct nucleotide sequencing of PCR products from the E6 open reading frame showed no sequence alterations in either normal or malignant samples.
Several distinct types of human papillomavirus (HPV) have been shown to be associated with both normal and abnormal oral epithelia (reviewed by Scully et al., 1988) . HPV DNAs of types 2, 4, 6, 11, 13, 16, 18, 32 and 57 have been demonstrated to occur in benign proliferative lesions of oral mucosa, including papillomas, verruca vulgaris and focal epithelial hyperplasia (Adler-Storthz et al., 1986a; Naghashfar et al., 1985; Pfister et al., 1983; Beaudenon et al., 1987; de Villiers et al., 1989); Greenspan et al. (1988) found HPV-7 DNA to be most common in oral warts in immunodeficient individuals seropositive for human immunodeficiency virus.
Oral cancer biopsies have also been shown, in some cases, to contain HPV sequences, de Villiers et al. (1985) and Adler-Storthz et al. (1986b) detected HPV-2 DNA in oral squamous and verrucous carcinomas, and DNAs of HPV-16 (de Villiers et al., 1985; Maitland et al., 1987) and HPV-18 (Syrjanen et al., 1988) have been reported in other oral squamous celt carcinomas. Additionally, Maitland et al. (1987 Maitland et al. ( , 1989 found that a large proportion of normal oral mucosal samples, as well as carcinomas, exclusively contain HPV-16 sequences, which in most cases varied from the prototype virus in their PstI restriction pattern.
We have used Southern blot hybridization and the polymerase chain reaction (PCR) to detect the presence of HPV DNA in biopsy samples of normal, dysplastic and malignant oral mucosae, and DNA sequencing to compare oral isolates of HPVs to prototype sequences.
DNA was prepared from 39 primary oral squamous cell carcinoma biopsies and adjacent dysplastic and normal tissue, and from 25 control samples of normal buccal mucosa from cancer-free individuals by the method of Chirgwin et al. (1979) . Aliquots (10 gg) of genomic DNAs were digested with PstI or HpalI and analysed by Southern blotting and hybridization to 3zp_ labelled probes containing the complete genomes of HPV types 1 to 7, 11, 13, 16 and 18. Hybridization to each probe was carried out first at low stringency (Tin -40 °C) and then at high stringency (Tm -10 °C). The DNAs of HPV types 4, 16 and 18 were identified in three individual carcinomas out of 39 (samples C4, C2 and C1, respectively) but not in dysplastic or normal tissues from the same cancer patients (Fig. 1 ) or in samples of normal buccal mucosa (data not shown). In each case viral DNA was present in the episomal form (data not shown) but integration of a single copy into the cellular DNA can not be ruled out. No hybridization was observed in any of the samples with the other HPV probes, although the equivalent of one copy of viral DNA per cell could always be detected in reconstruction samples.
In sample C2, which contained HPV-16 DNA, the 1-55 kb PstI fragment which maps to the L2-L1 region of the viral genome was missing, a finding similar to that of Maitland et al. (1987) . In an HpaII digest the expected 2.6 kb fragment which maps to the same region was absent and an additional band of approximately 0.9 to 1.0 kb was detected (Fig. 1, C2 , lanes l and 2). As viral DNA was in the episomal form, these data point to an alteration in the L2-LI region of the HPV-16 genome (W. A. Yeudall & M. S. Campo, unpublished results).
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In sample C1, the HPV-18 D N A contained an additional Pstl site in the 6-34 kb prototype fragment ( Fig. 1, C1 , lane 1). Different polymorphism of PstI restriction sites of HPV-18 has previously been reported in a cervical carcinoma biopsy in the west of Scotland (Millan et al. 1986) , indicating a degree of heterogeneity of this virus in the area.
HPV-4 D N A was found in sample C4 (Fig. 1, C4 , lanes 1 and 2). As this is the first association of this viral type with a malignant lesion, we molecularly cloned the viral D N A for more detailed analysis. Cellular D N A from sample C4 was digested with BamHI, and the linearized 8 kb viral D N A was first cloned in the bacteriophage vector EMBL3 (Stratagene) and then subcloned in the B a m H I site of pBR322. The 8 kb insert was compared to the prototype HPV-4 D N A both by restriction endonuclease digestion and by partial nucleotide sequencing. No differences were observed between the prototype HPV-4 and the newly cloned D N A using 12 restriction enzymes (data not shown) but nucleotide changes that do not create or delete a restriction site for one of the enzymes used would not be apparent.
As the complete nucleotide sequence of HPV-4 D N A has not yet been determined, we sequenced a region of the prototype HPV-4 genome immediately adjacent to the vector-viral junction using as a sequencing primer the 17-base oligomer 5' G C C G G C C A C G A T G C G T C 3', which corresponds to nucleotides 406 to 390 of the pBR322 genome, close to the B a m H I site (Sutcliffe, 1979) . Using a commercially available kit (Sequenase; United States Biochemicals) and the dideoxynucleotide chain termination method (Sanger et al., 1977) , 380 nucleotides were determined, reading from the 5' end of the HinclI site at map coordinate 0.018 to the HinclI site at map coordinate 0.05 (Heilman et al., 1980) . The first 150 nucleotides are shown in Fig. 2 . Using a synthetic oligonucleotide corresponding to nucleotides 4 to 23 ( Fig.  2 and 3a) as the sequencing primer, we compared prototype and oral HPV-4 and observed no nucleotide differences over the region sequenced (data not shown).
As previous reports have described the presence of HPV D N A in normal cervical and oral tissues as well as in carcinomas and dysplasias (Cox et al., 1986; Maitland et al., 1987) , we analysed all the oral biopsies by the PCR, which allows detection of minute amounts of D N A . Oligonucleotides were synthesized corresponding to the HPV-4 sequence obtained, the E6-E7 region of HPV-16 (Seedorf et al., 1985) and the E6 region of HPV-18 (Cole & Danos, 1987; Fig. 3a, c and e, respectively) . The E6-E7 region of HPV-16 and the E6 region of HPV-18 were chosen as they are usually retained in virus-positive carcinomas (Wilczynski et al., 1988) . HPV-4 primers were expected to amplify a fragment of 136 bp, HPV-16 primers a fragment of 166 bp and HPV-18 primers a fragment of 100 bp. Amplifications were carried out in a Perkin-Elmer Cetus D N A Thermal Cycler with 10 mMTris-HC1 pH 8.3, 50mM-KC1, 1.5 mM-MgC12, 0-01~ gelatin, 200 mM of each dNTP, 0.5 mg of each primer and 2.5 units of Taq polymerase. Samples were denatured for 10 min at 94 °C and cooled on ice prior to addition of enzyme. Thirty cymes of amplification at 94 °C (1 min), 50 °C (1 min) and 72 °C (1 min) were performed, followed by a final cycle of annealing at 50 °C (1 min) and extension at 72 °C for 10 min. Samples were analysed by electrophoresis in 6~ acrylamide gels, stained with ethidium bromide and visualized on a u.v. transilluminator. Southern transfers of the P C R fragments were hybridized at high stringency to the complete HPV-4 genome, or oligonucleotides internal to the amplified fragments in the case of HPV-16 and HPV-18 ( Fig. 3 c and e ). Membranes were washed three times for 20 min in 0.1 x SSC/0.1 ~ SDS and exposed to Kodak X-Omat S film for between 1 h and 5 days. The 136 bp fragment expected for HPV-4 was amplified in sample C4 and also in the adjacent dysplastic and normal tissues, 
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--100 bp samples D4 and N4 (Fig. 3b) . None of the remaining samples was positive using this set of primers. Of 39 cancer cases, 10 (25.6~) contained HPV-16 DNA and eight further cases (20-5 ~o) contained HPV-18 DNA. In addition, HPV-18 DNA was detected in two of 25 (8%) cancer-free samples (Fig. 3jO . Amplification was specific, as HPV-16 DNA was not amplified from an HPV-16-containing cell line (T45, derived from an oral carcinoma; Parkinson & Yeudall, 1990 ) using HPV-18 primers (Fig. 3f) . Anticontamination primers for HPV-16 (van den Brule et al., 1989 ) and HPV-18, which spanned the cloning sites, were used to control against the possibility of contamination by HPV plasmids present in our laboratory. Any contamination would result in an amplification product larger than the expected one by 4.3 kb, the size of the cloning vector. In reconstruction experiments, the large (approximately 4-5 kb) fragment could be amplified from 10pg of recombinant plasmid DNA. No evidence of such a fragment was found in any of the samples, showing the absence of contaminating plasmids. The expected 1 7 0 b p fragment of wild-type HPV-18 DNA was detected in each case found positive with HPV-18 E6 primers (data not shown), confirming that the presence of viral DNA in biopsies was not due to laboratory contamination. Using the HPV-16 anticontamination primers, which map to the late region of the viral genome, no amplification of viral sequences was observed in the HPV-16-positive cases, attributable to the extensive sequence alterations found in this region (Maitland et al., 1989; W. A. Yeudall & M. S. Campo, unpublished results) .
When viral DNA was present in carcinoma tissue, it was also found by PCR in adjacent dysplastic and normal tissues (Fig. 3) , except in two samples, N20 and N39 (Fig. 3j0 . The fact that viral DNA is only detectable by PCR may reflect a low number of cells infected with virus in a much larger population of uninfected cells, thus reducing the apparent copy number per cell.
The presence of HPV-4 DNA in sample 4 was a novel, though isolated, finding. HPV-4 infection is normally associated with benign skin lesions rather than mucosal proliferations, although it has previously been detected in one case of oral verruca vulgaris (Adler-Storthz et al., 1986a) . It is unclear what role, if any, HPV-4 has in the aetiology of oral cancer as it is present in ceils of normal histological appearance and its incidence in oral mucosa is low compared to other HPV types.
An interesting finding was the detection of HPV-18 DNA in two samples of normal oral epithelium from Thus it would appear that DNAs of several HPV types may infect oral epithelium at low levels and do not necessarily result in pathology either at the clinical or histological level. The function of papillomavirus DNA in oral mucosae remains an unanswered question but the use of PCR to study transcription of viral genes, undetectable in these tissues by conventional means, will undoubtedly help to clarify this point and may shed some light on the possible role of HPV DNA in the onset of malignant oral disease.
